Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuropsychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/npp.2017.209PMID 28875990PMCID PMC5719112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nabilone

  2019cited by this paper
• Cannabinoids in treatment-resistant epilepsy: A review.

  2017cited by this paper
• The current status of artisanal cannabis for the treatment of epilepsy in the United States.

  2017cited by this paper
• A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics

  2017cited by this paper
• Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.

  2017cited by this paper
• Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys

  2017cited by this paper
• Cannabinoid‐Induced Tetrad in Mice

  2017cited by this paper
• Phytochemistry of Cannabis sativa L.

  2017cited by this paper
• Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.

  2016cited by this paper
• Medical Marijuana for Epilepsy?

  2016cited by this paper
• Sex-dependent effects of cannabis-induced analgesia.

  2016cited by this paper
• Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies

  2016cited by this paper
• Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.

  2016influential reference
• Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study

  2016cited by this paper
• Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis

  2016cited by this paper
• Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.

  2016cited by this paper
• Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.

  2016cited by this paper
• Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

  2015cited by this paper
• Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

  2015cited by this paper
• Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9‐tetrahydrocannabinol in Sprague‐Dawley rats

  2015influential reference
• Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum

  2015cited by this paper
• Endocannabinoid signaling in reward and addiction

  2015cited by this paper
• A systematic review of the antipsychotic properties of cannabidiol in humans.

  2015cited by this paper
• Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.

  2015cited by this paper
• Neural correlates of interactions between cannabidiol and Δ9‐tetrahydrocannabinol in mice: implications for medical cannabis

  2015influential reference
• Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Effects of Fatty Acid Amide Hydrolase ( FAAH ) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse

  2015cited by this paper
• Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

  2015cited by this paper
• Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

  2015influential reference
• A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.

  2014cited by this paper
• Cannabidiol reverses the mCPP‐induced increase in marble‐burying behavior

  2014cited by this paper
• Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.

  2014cited by this paper
• Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.

  2014cited by this paper
• The case for medical marijuana in epilepsy

  2014cited by this paper
• Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol

  2013cited by this paper
• Spicing things up: synthetic cannabinoids

  2013cited by this paper
• Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.

  2013cited by this paper
• Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

  2013cited by this paper
• Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.

  2012cited by this paper
• Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?

  2012cited by this paper
• Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors

  2012cited by this paper
• Persistent cannabis users show neuropsychological decline from childhood to midlife

  2012cited by this paper
• On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment

  2012cited by this paper
• Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

  2012influential reference
• Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

  2012cited by this paper
• Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.

  2011cited by this paper
• Cannabis with high cannabidiol content is associated with fewer psychotic experiences.

  2011cited by this paper
• Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration

  2011influential reference
• Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats

  2011cited by this paper
• Synthetic delta‐9‐tetrahydrocannabinol elicits schizophrenia‐like negative symptoms which are distinct from sedation

  2011cited by this paper
• Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

  2011cited by this paper
• Heterogeneity in the composition of marijuana seized in California.

  2011influential reference
• Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data

  2011cited by this paper
• Faculty Opinions recommendation of Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

  2011influential reference
• Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids

  2011cited by this paper
• A randomized, double‐blind, placebo‐controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

  2011influential reference
• Non‐psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action

  2011cited by this paper
• Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

  2011influential reference
• Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.

  2011cited by this paper
• Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

  2010influential reference
• Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

  2010influential reference
• Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation

  2010cited by this paper
• Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.

  2010cited by this paper
• Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells.

  2010cited by this paper
• Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

  2010influential reference
• Retrograde Endocannabinoid Signaling Reduces GABAergic Synaptic Transmission to Gonadotropin-Releasing Hormone Neurons

  2010cited by this paper
• Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels

  2010cited by this paper
• Animal models of cannabinoid reward

  2010cited by this paper
• Central nervous system effects of haloperidol on THC in healthy male volunteers

  2010cited by this paper
• Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels

  2010cited by this paper
• Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.

  2009cited by this paper
• Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

  2009cited by this paper
• 5‐HT1A receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats

  2009cited by this paper
• Roles of the endocannabinoid system in learning and memory.

  2009cited by this paper
• The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

  2009cited by this paper
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines

  2009cited by this paper
• Stress-related factors in cannabis use and misuse: implications for prevention and treatment.

  2009cited by this paper
• Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

  2009cited by this paper
• Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.

  2008cited by this paper
• Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.

  2008cited by this paper
• Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

  2008cited by this paper
• Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

  2008influential reference
• CB2 receptors in the brain: role in central immune function

  2008cited by this paper
• Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.

  2008cited by this paper
• Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.

  2008cited by this paper
• Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

  2008influential reference
• Endocannabinoids and Synaptic Function in the CNS

  2007influential reference
• Cannabidiol – Recent Advances

  2007cited by this paper
• Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

  2007cited by this paper
• Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

  2007influential reference
• Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

  2006cited by this paper
• Interactions between THC and cannabidiol in mouse models of cannabinoid activity

  2006influential reference
• Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

  2006cited by this paper
• A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.

  2006cited by this paper
• Cannabidiol monotherapy for treatment-resistant schizophrenia

  2006cited by this paper
• The acute effects of cannabinoids on memory in humans: a review

  2006influential reference
• Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

  2005cited by this paper
• Self-administration of cannabinoids by experimental animals and human marijuana smokers.

  2005cited by this paper
• Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of Δ9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract

  2005influential reference

• Naturalistic investigation of cannabis strains varying in THC and CBD ratios and verbal recognition memory

  2026cites this paper
• Toxicity and health effects of delta-8, delta-9, and delta-10-tetrahydrocannabinol and unregulated cannabinoids in vaping products

  2026influential citation
• Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3)

  2025cites this paper
• Microalgae and exercise: from molecular mechanisms and brain health to clinical perspectives in the context of 3P medicine

  2025cites this paper
• Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence

  2025cites this paper
• Cannabis and Health: Exploring Risks, Benefits and Research Horizons

  2025cites this paper
• Cannabidiol-Based Thiosemicarbazones: A Preliminary Study Evaluating Their Anti-Tyrosinase Properties

  2025cites this paper
• In vitro antimicrobial activity of Thai stick cannabis Hang Kra Rog Phu Phan (Cannabis sativa L.), sugar leaves extract against pathogenic bacteria

  2025cites this paper
• Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent cannabis use

  2025cites this paper
• Medical Cannabis and Epilepsy: The Evidence.

  2025cites this paper
• Supplementing HIV-ART with cannabinoids increases serotonin, BHB, and Ahr signaling while reducing secondary bile acids and acylcholines

  2025cites this paper
• Cannabis Intoxication: a New and Evolving Concern for Sports Medicine

  2025cites this paper
• Cannabidiol interactions with Δ-9-tetrahydrocannabinol on antinociception after carrageenan-induced inflammatory pain in male and female rats.

  2025cites this paper
• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• Acute cannabidiol (CBD), tetrahydrocannabinol (THC) and their mixture (THC:CBD) exert differential effects on brain activity and blood flow in rats: A translational neuroimaging study.

  2025cites this paper
• Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice

  2025cites this paper
• Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks

  2025cites this paper
• Cannabidiol (CBD) and Colorectal Tumorigenesis: Potential Dual Modulatory Roles via the Serotonergic Pathway

  2025cites this paper
• Persistent behavioural consequences of chronic adolescent cannabidiol (CBD) in a mouse model with increased susceptibility to Δ9-tetrahydrocannabinol and schizophrenia.

  2025cites this paper
• Carvone derived cannabidiol enantiomers as novel anticonvulsants

  2025cites this paper
• The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications.

  2025cites this paper
• Exploring Natural Analgesics for Chronic Pain Management: Cannabinoids and Other Phytoconstituents.

  2025cites this paper
• Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Rhodium-Catalyzed Asymmetric Addition to 4- or 5-Carbonyl-cycloenones through Dynamic Kinetic Resolution: Enantioselective Synthesis of (-)-Cannabidiol.

  2024cites this paper
• Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial

  2024cites this paper
• DYZY01 alleviates pulmonary hypertension via inhibiting endothelial cell pyroptosis and rescuing endothelial dysfunction.

  2024cites this paper
• A comprehensive update on cannabidiol, its formulations and drug delivery systems

  2024cites this paper
• Cannabinoid-Induced Stereoselective Inhibition of R-S-Oxazepam Glucuronidation: Cannabinoid–Oxazepam Drug Interactions

  2024cites this paper
• Nabiximols (NBX) suppresses tremor in a rat Harmaline model of essential tremor.

  2024cites this paper
• Impact of Medical Cannabis on Recovery from Playing-Related Musculoskeletal Disorders in Musicians: An Observational Cohort Study

  2024cites this paper
• The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review

  2024cites this paper
• Identification of Aspergillus westerdijkiae and its potential risk of Ochratoxin A synthesis in Cannabis inflorescences

  2024cites this paper
• Genotoxicity study of Cannabis sativa L. extract

  2024cites this paper
• Effect of preoperative oral cannabidiol-rich Cannabis extract on anxiety and postoperative pain after endodontic treatment: A double-blind randomized clinical trial.

  2024cites this paper
• Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats

  2024cites this paper
• Identification and Health Risks of an Emerging Means of Drug Use in Correctional Facilities

  2024cites this paper
• Cannabinoid treatment for the symptoms of autism spectrum disorder

  2024cites this paper
• Cannabis use disorder: from neurobiology to treatment

  2024cites this paper
• A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

  2023cites this paper
• Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach

  2023cites this paper
• CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE.

  2023cites this paper
• Physician Perceptions of Cannabidiol (CBD) and Cannabis in Sports Medicine and Performance

  2023cites this paper
• The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review

  2023cites this paper
• Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products

  2023cites this paper
• Women are Taking the Hit: Examining the Unique Consequences of Cannabis Use Across the Female Lifespan.

  2023cites this paper
• Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms

  2023cites this paper
• MICROSCOPIC ARCHITECTURE OF THE LIVER OF EXPERIMENTAL RATS AFTER CANNABIDIOL OIL APPLICATIONS

  2023cites this paper
• Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review

  2023cites this paper
• Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds

  2023influential citation
• Le potentiel thérapeutique du cannabidiol chez les sujets présentant un trouble du spectre psychotique : une revue systématique de la littérature sur les essais contrôlés randomisés

  2023cites this paper
• A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR‐1 mediated mitochondrial dysfunction and apoptosis

  2023cites this paper
• Oxycodone Self-Administration in Female Rats is Enhanced by ∆9-tetrahydrocannabinol, but not by Cannabidiol, in a Progressive Ratio Procedure

  2023cites this paper
• Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome

  2023cites this paper
• THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

  2023cites this paper
• Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults

  2023cites this paper
• Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults

  2023cites this paper
• Cannabis and sleep disorders: not ready for prime time? A qualitative scoping review

  2023cites this paper
• Categorization of Marijuana Suspected Policies’ Seizures in Southeast Serbia according to Cannabinoids Content

  2023cites this paper
• Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders

  2022cites this paper
• Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation

  2022cites this paper
• Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine

  2022cites this paper
• A Clinical Framework for Assessing Cannabis-Related Impairment Risk

  2022cites this paper
• High Potency Cannabis Use in Adolescence.

  2022cites this paper
• Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior

  2022cites this paper
• Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2

  2022cites this paper
• A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome

  2022cites this paper
• Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?

  2022influential citation
• Driving under the influence of drugs: Correlation between blood psychoactive drug concentrations and cognitive impairment. A narrative review taking into account forensic issues

  2022cites this paper
• Marijuana use does not affect weight loss or complication rate after bariatric surgery

  2022cites this paper
• Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential

  2022cites this paper
• A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use

  2022cites this paper
• Cannabis Use and the Endocannabinoid System: A Clinical Perspective.

  2022cites this paper
• Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

  2022cites this paper
• Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)

  2022cites this paper
• Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy

  2022cites this paper
• Preventing Oversight on Medical Cannabis Legislation in Malaysia: Analysis of Risks, Benefits and Regulation Requirements

  2022influential citation
• Perceptions about THC and CBD effects among adults with and without prior cannabis experience.

  2022cites this paper
• The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans

  2022cites this paper
• Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  2022cites this paper
• Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

  2022cites this paper
• Title: Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?

  2021cites this paper
• Cannabinoids: revealing their complexity and role in central networks of fear and anxiety.

  2021cites this paper
• Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101

  2021influential citation
• Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person.

  2021cites this paper
• The Impact of THC and CBD in Schizophrenia: A Systematic Review

  2021cites this paper
• The phytochemical diversity of commercial Cannabis in the United States

  2021cites this paper
• Establishing and Evaluating a Study Questionnaire on Knowledge and Attitudes of Healthcare Professionals Towards Recreational and Medical Cannabis Across Europe

  2021cites this paper
• Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

  2021cites this paper
• ISSN: 2595-6825

  2021cites this paper
• Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making

  2021cites this paper
• Development of a novel cannabinoid-loaded microemulsion towards an improved stability and transdermal delivery.

  2021cites this paper
• "Is medical cannabis safe for my patients?" A practical review of cannabis safety considerations.

  2021cites this paper
• Effects of vapor exposure to Δ9-tetrahydrocannabinol (THC) in the Maine Lobster (Homarus americanus)

  2021cites this paper
• Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?

  2021cites this paper
• Beyond the high: Mapping patterns of use and motives for use of cannabis as medicine

  2021influential citation
• Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

  2021cites this paper
• Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors

  2021cites this paper
• Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update.

  2021cites this paper